C67
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: o Primary carcinomas of the urinary bladder (no exclusion of specific histologies) o Curative intent of radiochemotherapy o cM0 at the time of radiochemotherapy o Start of radiochemotherapy for bladder cancer between 01/01/2008 and 12/31/2024 o Age =18 years at the time of radiochemotherapy o Written informed consent to participate in the study
Exclusion criteria
Exclusion criteria: o Palliative radiotherapy o Postoperative radio(chemo)therapy after cystectomy o Lack of ability to understand the German questionnaires
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bladder function–related quality of life (assessed using the EORTC QLQ-BLM30 questionnaire) | — |
Secondary
| Measure | Time frame |
|---|---|
| General quality of life (EORTC QLQ-C30) Decision regret (Decision Regret Scale, DRS) Psychological distress (NCCN Distress Thermometer) Anxiety (Generalized Anxiety Disorder Scale-7, GAD-7) Depression (Patient Health Questionnaire-9, PHQ-9) Fear of cancer progression (Fear of Progression Questionnaire–Short Form, FoP-Q-SF) | — |
Countries
Austria, Germany
Contacts
Klinik und Poliklinik für Strahlentherapie,Universitätsklinikum Leipzig